Tekla Capital Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $848K | Buy |
256,888
+198,351
| +339% | +$655K | 0.03% | 131 |
|
|
2023
Q1 | $167K | Hold |
58,537
| – | – | 0.01% | 168 |
|
|
2022
Q4 | $426K | Buy |
+58,537
| New | +$426K | 0.02% | 151 |
|
|
2022
Q3 | – | Sell |
-58,537
| Closed | -$287K | – | 176 |
|
|
2022
Q2 | $287K | Sell |
58,537
-18,756
| -24% | -$92K | 0.01% | 165 |
|
|
2022
Q1 | $1.83M | Hold |
77,293
| – | – | 0.06% | 128 |
|
|
2021
Q4 | $1.37M | Buy |
77,293
+33,395
| +76% | +$591K | 0.04% | 139 |
|
|
2021
Q3 | $1.24M | Buy |
+43,898
| New | +$1.24M | 0.04% | 147 |
|